simendan has been researched along with Tachyarrhythmia in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dabrowski, W; Jaroszynski, A; Piasek, E; Schlegel, TT; Siwicka-Gieroba, D | 1 |
Cheng, CP; Cheng, HJ; Little, WC; Masutani, S; Tachibana, H | 1 |
Arocas-Casañ, V; Blázquez-Álvarez, MJ; Cárceles-Barón, MD; de la Rubia-Nieto, A; Fernández de Palencia-Espinosa, MA | 1 |
3 other study(ies) available for simendan and Tachyarrhythmia
Article | Year |
---|---|
Successful Combination of Landiolol and Levosimendan in Patients with Decompensated Heart Failure.
Topics: Adrenergic beta-Antagonists; Aged; Cardiotonic Agents; Drug Therapy, Combination; Female; Heart Failure; Humans; Male; Morpholines; Simendan; Tachycardia; Urea | 2020 |
Levosimendan restores the positive force-frequency relation in heart failure.
Topics: Analysis of Variance; Animals; Cardiac Pacing, Artificial; Cardiotonic Agents; Disease Models, Animal; Dogs; Excitation Contraction Coupling; Heart Failure; Heart Rate; Hydrazones; Male; Myocardial Contraction; Pyridazines; Simendan; Stroke Volume; Tachycardia; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Pressure | 2011 |
[Retrospective descriptive study about the use of levosimendan in children undergoing surgical correction for congenital heart disease].
Topics: Cardiotonic Agents; Child, Preschool; Comorbidity; Compassionate Use Trials; Coronary Circulation; Down Syndrome; Drug Evaluation; Female; Heart Defects, Congenital; Hemodynamics; Humans; Hydrazones; Hypotension; Infant; Infant, Newborn; Kaplan-Meier Estimate; Male; Myocardial Ischemia; Postoperative Complications; Potassium Channels; Pyridazines; Retrospective Studies; Salvage Therapy; Simendan; Tachycardia | 2012 |